You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Richmond Brothers, Inc | 5,183,152 | 5,245,489 | 5,183,152 | 5,245,489 | 5,183,152 | 10.1% |
| RBI Private Investment I | 164,841 | 5,251,624 | 164,841 | 5,251,624 | 164,841 | Less than 1% |
| RBI PI Manager | 164,841 | 0 | 164,841 | 0 | 164,841 | Less than 1% |
| Richmond Brothers 401(k) Profit Sharing Plan | 34,087 | 0 | 34,087 | 0 | 34,087 | Less than 1% |
| David S. Richmond | 341,253 | 341,253 | 5,586,742 | 10.8% | ||
| Matthew J. Curfman | 40,684 | 40,684 | 5,292,308 | 10.3% | ||
| Norman J. Ravich Irrevocable Trust | 44,400 | 44,400 | 44,400 | Less than 1% | ||
| Norman and Sally Ravich Family Trust | 18,500 | 18,500 | 18,500 | Less than 1% | ||
| Alexander Coleman Ravich 1991 Irrevocable Trust | 25,000 | 25,000 | 25,000 | Less than 1% | ||
| Alyssa Danielle Ravich 1991 Irrevocable Trust | 25,000 | 25,000 | 25,000 | Less than 1% | ||
| Mark H. Ravich | 467,650 | 467,650 | 467,650 | Less than 1% |
Page 1 of 17 – SEC Filing
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
§ 240.13d-2(a)
(Amendment No. 2)1
Rockwell Medical, Inc.
(Name of Issuer)
Common Stock, no par value per share
(Title of Class of Securities)
774374102
(CUSIP Number)
DAVID S. RICHMOND
RICHMOND BROTHERS, INC.
3568 Wildwood Avenue
Jackson, Michigan 49202
(517) 435-4040
STEVE WOLOSKY
OLSHAN FROME WOLOSKY LLP
1325 Avenue of the Americas
New York, New York 10019
(212) 451-2300
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
March 17, 2017
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box x.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7 for other parties to whom copies are to be sent.
_______________
1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Follow Rockwell Medical Inc. (NASDAQ:RMTI)
Follow Rockwell Medical Inc. (NASDAQ:RMTI)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
Page 1 of 17
